Postmarketing Surveillance of Prescription Drugs

NTIS order #PB83-173625

Report cover

Full Report ~541K
Front Matter ~26K
Table of Contents ~9K

1: Summary ~43K
2: The Drug Approval Process ~46K
3: History and Objectives of Postmarketing Surveillance ~35K
4: Methods of Drug Evaluation ~75K
5: Current Activities ~126K
6: Issues and Options ~39K

A: Selected Excerpts From the Statutes Governing Drugs and Medical Devices ~16K
B: Conclusions and Recommendations of the Joint Commission on Prescription Drug Use, Jan. 23,1980 ~12K
References ~135K
Index ~31K